New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents
Open Access
- 31 May 2004
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 31 (4), 459-468
- https://doi.org/10.1016/j.nucmedbio.2003.10.013
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agentsBioorganic & Medicinal Chemistry Letters, 2003
- Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targetsInternational Journal of Cancer, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Imaging metalloproteinase activity in vivoNature Medicine, 2001
- New Functions of Stromal Proteases and Their Inhibitors in Tumor ProgressionSurgical Oncology Clinics of North America, 2001
- Matrix Metalloproteinases: Biologic Activity and Clinical ImplicationsJournal of Clinical Oncology, 2000
- Structure−Activity Relationships and Pharmacokinetic Analysis for a Series of Potent, Systemically Available Biphenylsulfonamide Matrix Metalloproteinase InhibitorsJournal of Medicinal Chemistry, 2000
- Matrix MetalloproteinasesJournal of Biological Chemistry, 1999
- Changing views of the role of matrix metalloproteinases in metastasisJNCI Journal of the National Cancer Institute, 1997
- Matrix metal loproteinases and the development of cancerChemistry & Biology, 1996